Abbott/ABT

$119.59

0.16%
-
1D1W1MYTD1YMAX

About Abbott

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

Ticker

ABT

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Robert Ford

Employees

114,000

Headquarters

Abbott park, United States

Abbott Metrics

BasicAdvanced
$205.95B
Market cap
36.27
P/E ratio
$3.27
EPS
0.74
Beta
$2.04
Dividend rate
1.85%
Dividend yield

What the Analysts think about Abbott

Analyst Ratings

Majority rating from 24 analysts.
Buy

Price Targets

Average projection from 19 analysts.
4.83% upside
High $141.00
Low $107.00
$119.59
Current price
$125.37
Average price target

Abbott Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
15.56% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$10.24B
0.97%
Net income
$1.59B
11%
Profit margin
15.56%
9.96%

Abbott Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 0.1%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$1.03
$1.08
$1.14
$1.19
-
Expected
$0.99
$1.05
$1.10
$1.19
$0.96
Surprise
4.27%
2.89%
3.85%
0.1%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Abbott stock

Buy or sell Abbott stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing